Actinogen Med Ltd.Actinogen Med Ltd.Actinogen Med Ltd.

Actinogen Med Ltd.

No trades
See on Supercharts
Next report date
Report period
H2 2024
EPS estimate
Revenue estimate
Market capitalization
‪45.60 M‬USD
−0.0046USD
‪−7.16 M‬USD
‪1.98 B‬
Beta (1Y)
1.87

About ACTINOGEN MEDICAL LIMITED

CEO
Steven G. Gourlay
Headquarters
Sydney
Founded
1999
ISIN
AU000000ACW3
FIGI
BBG00L33GRQ8
Actinogen Medical Ltd. is a clinical stage Australian biotechnology company, which focuses on the development of novel treatments or cognitive impairment associated with neurological, psychiatric, and metabolic diseases due to raised cortisol. The company was founded by Geoff E. D. Brooke & David Keast on March 23, 1999 and is headquartered in Sydney, Australia.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ATGGF is 0.0150 USD — it has increased by 15.38% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Actinogen Med Ltd. stocks are traded under the ticker ATGGF.
Actinogen Med Ltd. is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
ATGGF stock is 13.33% volatile and has beta coefficient of 1.87. Check out the list of the most volatile stocks — is Actinogen Med Ltd. there?
Yes, you can track Actinogen Med Ltd. financials in yearly and quarterly reports right on TradingView.
ATGGF net income for the last quarter is ‪−7.87 M‬ USD, while the quarter before that showed ‪−2.21 M‬ USD of net income which accounts for −256.51% change. Track more Actinogen Med Ltd. financial stats to get the full picture.
Today Actinogen Med Ltd. has the market capitalization of ‪45.60 M‬, it has increased by 10.22% over the last week.
No, ATGGF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ATGGF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Actinogen Med Ltd. stock right from TradingView charts — choose your broker and connect to your account.
ATGGF reached its all-time high on Jan 9, 2023 with the price of 0.1000 USD, and its all-time low was 0.0100 USD and was reached on Aug 9, 2019.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Actinogen Med Ltd. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Actinogen Med Ltd. stock shows the sell signal. See more of Actinogen Med Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.